Exchange: NASDAQ·Updated 02:29 PM EDT
MBRX logo

MBRX Moleculin Biotech Inc

$0.6538
$0.0091
(1.41%)
Today
Mkt Cap$12.56M
Vol225,058.00

About MBRX

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.
53

Neutral Sentiment

How do you feel about MBRX?

Advertisement|Remove ads.